Hera - Mi
Nantes
About Hera - Mi
Hera - Mi is Specialized in digital medical imaging applied to breast cancer.Hera-MI has developed clinical decision support solutions to help improve early-stage breast cancer detection. Our solutions will improve the quality and accuracy of breast cancer diagnosis while decreasing radiologists’ interpretation time. Patients will be treated more quickly, offering them a better chance of remission. Hera-MI has developed Breast-SlimView, a clinical decision support software based on artificial intelligence and image processing for breast cancer diagnosis. Our partner, Fujifilm is selling Breast-SlimView in France and in the Overseas Territories of France (DROM/TOM). Breast-SlimView is also available for sale all over the world.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Last round: Non-Equity Assistance (Oct 2020)
- Website: hera-mi.com
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/hera-mi-2430199 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.